Showing results (61-70 of 358) with videos related to
Sort By:
Pageof 36
Bone Marrow Transplantation|June 1, 1990
Veno-occlusive disease of the liver complicating ABMT successfully treated with recombinant tissue plasminogen activator (rt-PA)T P Baglin, P Harper, R E MarcusBlood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 15, 1998
Cleavage of rhamnose from ristocetin A removes its ability to induce platelet aggregationB Bardsley, D H Williams, T P BaglinLa Nouvelle Presse Medicale|May 19, 1979
[Study of the effect of dopamine on renal excretion in chronic renal failure (author's transl)]A Baglin, A Goupil, M Domart, et al.Journal Francais D'Ophtalmologie|April 3, 2012
Intravitreal ranibizumab injection for choroidal neovascularization in Strümpell-Lorrain SyndromeT H C Tran, G Baglin, G QuerquesTransplantation|April 15, 1994
Predictive value of von Willebrand factor to ristocetin cofactor ratio and thrombin-antithrombin complex levels for hepatic vessel thrombosis and graft rejection after liver transplantationI Jennings, R Y Calne, T P BaglinThrombosis Research|October 23, 1997
The effect of delayed analysis or freeze-thawing on the measurement of natural anticoagulants, resistance to activated protein C and markers of activation of the haemostatic systemR Luddington, J Peters, P Baker, et al.Cancer Genetics and Cytogenetics|July 1, 1987
Therapy-related acute nonlymphocytic leukemia with inversion of chromosome 16 and a sustained remissionT P Baglin, G P Galvin, A PollockAmerican Journal of Pharmaceutical Education|January 17, 2026
Wellbeing of pharmacy students during the preparation period of national pharmacy internship competition in FranceCaroline Lefeuvre, Isabelle Baglin, Sébastien Faure, et al.Journal of Chromatography|October 4, 1991
Liquid chromatographic analysis of propranolol enantiomers in human blood using precolumn derivatization with (+)-1-(9-fluorenyl)ethyl chloroformateA Roux, G Blanchot, A Baglin, et al.Leukemia & Lymphoma|July 28, 2016
A Pilot Study of Low Dose ARA-C, Interferon-Alpha and Cis-Retinoic Acid (AIR) Combination Therapy for Poor Risk Patients with Acute Myeloid LeukaemiaS H Lim, R E Marcus, T P BaglinPageof 36